RxDoctor Payments Data

Kristin Austria, NP

Nurse Practitioner · Virginia Beach, VANPI 1750893434

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 84.2% of it on its own, with 12 other manufacturers making up the rest. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,616in general payments, 2019–2025

Across 254 payments — averaging $100.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$22K
  • Medtronic$1K
  • Sumitomo Pharma America, Inc.$749
  • Coloplast$517
  • Endo Pharmaceuticals Inc.$346
  • C. R. Bard, Inc. & Subsidiaries$319
  • plus $744 from 7 others

What the payments were for

  • Consulting fees$6703%
  • Speaking & faculty fees$12,76650%
  • Travel & lodging$8,41833%
  • Food & beverage$3,39713%
  • Education$3641%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,616 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$220,243
Medicare patients
853
Services billed
10,623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron387$374,352
MyrbetriqMirabegron235$203,506
Mirabegron ErMirabegron33$26,965
Trospium Chloride243$26,340
Estradiol274$19,740
Trospium Chloride ErTrospium Chloride75$16,287
PremarinEstrogens, Conjugated28$13,018
Darifenacin ErDarifenacin Hydrobromide69$8,658
Tamsulosin Hcl231$3,519
Trimethoprim49$2,526
Tolterodine Tartrate ErTolterodine Tartrate17$2,354
Methenamine Hippurate18$1,702
Desmopressin Acetate20$1,442
Solifenacin Succinate40$1,225
Fesoterodine Fumarate ErFesoterodine Fumarate23$997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$749$374,352387 claims
Astellas Pharma US IncMyrbetriq$237$203,506235 claims
PfizerPremarin$118$13,01828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →